Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma

SIMPLE SUMMARY: Both BR, and R-BAC are suitable induction therapies in elderly patients with mantle cell lymphoma (MCL). However, the two regimens have not been compared before. We retrospectively analysed the outcome and the safety features of elderly patients with newly diagnosed MCL, treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Bega, Giulia, Olivieri, Jacopo, Riva, Marcello, Scapinello, Greta, Paolini, Rossella, Finotto, Silvia, Sartori, Roberto, Lucchini, Elisa, Guandalini, Gianmarco, Facchinelli, Davide, Tisi, Maria Chiara, Basso, Marco, Ballotta, Laura, Piazza, Francesco, Ferrarini, Isacco, Visco, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657015/
https://www.ncbi.nlm.nih.gov/pubmed/34885198
http://dx.doi.org/10.3390/cancers13236089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657015/
https://www.ncbi.nlm.nih.gov/pubmed/34885198
http://dx.doi.org/10.3390/cancers13236089

Ejemplares similares